Identification of Candidate Cancer Chemopreventive Agents and Their Evaluation in Animal Models and Human Clinical Trials: A Review

Cancer Research

Volumn 50, Issue 1, 1990, Pages 2-9

  Boone, Charles W ^a   Kelloff, Gary J ^a   Malone, Winfred E ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

3 INDOLEMETHANOL; BENZYL ISOTHIOCYANATE; BETA CAROTENE; EFLORNITHINE; ELLAGIC ACID; FENRETINIDE; FLUOCINOLONE; MOLYBDIC ACID; OLTIPRAZ; PIROXICAM; SALAZOSULFAPYRIDINE; SELENIUM; TAMOXIFEN;

ANIMAL MODEL; CANCER PREVENTION; CHEMOPROPHYLAXIS; CLINICAL TRIAL; HAMSTER; HUMAN; MOUSE; NONHUMAN; PRIORITY JOURNAL; RAT; REVIEW;

ANIMAL; ANTINEOPLASTIC AGENTS; CLINICAL TRIALS; DRUG EVALUATION, PRECLINICAL; FEMALE; HUMAN; NEOPLASMS; NEOPLASMS, EXPERIMENTAL;

EID: 0025021731     PISSN: 00085472     EISSN: 15387445     Source Type: Journal    
DOI: None     Document Type: Article

References (85)

1. Wattenberg, L. W. Chemoprevention of cancer. Cancer Res., 45: 1–8, 1985.
2. Slaga, T. J., Fischer, S. M., Weeks, C. E., Nelson, K., Mamrake, M., and Klein-Szants, A. J. Specificity and Mechanisms of Promoter Inhibitors in Multistage Promotion. Compr. Surv., 7: 19–34, 1982.
3. McCormick, D. O., Mehta, R. G., and Thompson, C. A., et al. Enhanced inhibition of mammary carcinogenesis by combined treatment with N-{4-hydroxphenyl) retinamide and ovariectomy. Cancer Res., 42: 508–512, 1982.
4. Thompson, H. J., Becci, P. J., Brown, C. C., and Moon, R. C. Effect of the duration of retinyl acetate feeding on inhibition of N-methyl-N-nitrosourea-induced mammary carcinogenesis in the rat. Cancer Res., 39: 3977–3980, 1979.
5. Grubbs, C. J., Becci, P. J., Thompson, H. J., and Moon, R. C. Carcinogenicity of N-methyl-N-nitrosourea and N-ethyl-N-nitrosourea when applied to a localized area of the hamster trachea. J. Natl. Cancer Inst., 66: 961–965, 1981.
6. Reznik-Schuller, H. M., and Reznik, G. Experimental pulmonary carcinogenesis. Int. Rev. Exp. Pathol., 20: 211–219, 1979.
7. Schuller, H. J., and McMahon, J. B. Inhibition of nitroso-diethylamine-induced respiratory tract carcinogenesis by piperonyl butoxide in hamsters. Cancer Res., 45: 2807–2812, 1985.
8. Becci, P. J., Thompson, H. J., Strum, J. M., Brown, C. C., Sporn, M. B., and Moon, R. C. N-Butyl-N-(4-hydroxybutyl)nitrosamine-induced urinary bladder cancer in C57BL/6 x DBS/2 Ft mice as a useful model for study of chemoprevention of cancer with retinoids. Cancer Res., 41: 927–932, 1981.
9. McCormick, D. L. et al. Influence of total dose and dose schedule on induction of urinary bladder cancer in the mouse by N-butyl-.N-(4-hydroxybutyl)nitrosamine. Carcinogenesis (Lond.), 2: 251–254, 1981.
10. Ward, J. M. Dose response to a single injection of azoxymethane in rats. Vet. Pathol., 12: 165–177, 1975.
11. Reddy, B. S., and Maeura, Y. Tumor promotion by dietary fat in azoxy-methane-induced colon cancer. Carcinogenesis in female F-344 rats: Influence of amount and source of dietary fat. J. Natl. Cancer Inst., 72: 745–750, 1984.
12. Reddy, B. S., and Maeura, Y. Dose-response studies of the effect of dietary butylated hydroxyanisole on colon carcinogenesis induced by methylazoxy-methanol acetate in female CF1 mice. J. Natl. Cancer Inst., 72: 1181–1187, 1984.
13. Willett, W. C., and Stampfer, M. J. Selenium and human cancer: epidemiological aspects and implications for clinical trials. J. Am. Col. Toxicol., 5: 29–36, 1986.
14. Ip, C. The chemopreventive role of selenium in carcinogenesis. J. Am. Col. Toxicol., 5: 7–20, 1986.
15. Proceedings of the Workshop, Strategies Needed to Develop Selenium Compounds as Cancer Preventive Agents, February 8, 1985, National Cancer Institute. J. Am. Col. Toxicol., 5: 1–10, 1986.
16. Wei, H. J., Luo, X. M., and Yang, S. P. Effects of molybdenum and tungsten on mammary carcinogenesis in SD rats. J. Natl. Cancer Inst., 74: 469–473, 1985.
17. Pashko, L. L., Hard, G. C., Rovito, R. J., Williams, J. R., Sobel, E. L., and Schwartz, A. G. Inhibition of 7, 12-dimethylbenz(a)anthracene-induced skin papillomas and carcinomas by dehydroepiandrosterone and 3–0-methylan-drost-5-ene-17-one in mice. Cancer Res., 45: 164–166, 1985.
18. Schwartz, A. G. Inhibition of spontaneous breast cancer formation in female C3H (Avy/a) mice by long term treatment with dehydroepiandrosterone. Cancer Res., 39: 1129–1132, 1979.
19. Nyce, J. W., Magee, P. N., Hard, G. C., and Schwartz, A. G. Inhibition of 1, 2-dimethylhydrazine-induced colon tumorigenesis in Balb/c mice by dehydroepiandrosterone. Carcinogenesis (Lond.), 5: 57–62, 1984.
20. Schwartz, A. G., and Tannen, R. H. Inhibition of 7, 12-dimethylbenz(a)anthracene and urethane-induced lung tumor formation in A/J mice by long-term treatment with dehydroepiandrosterone. Carcinogenesis (Lond.), 2: 1335–1337, 1981.
21. Pashko, L. L., and Schwartz, A. G. Effect of food restriction, dehydroepiandrosterone and obesity on the binding of 7, 12-dimethylbenz(a)anthracene to mouse skin DNA. J. Gerontol., 38: 8–12, 1983.
22. Schwartz, A. G., Whitcomb, J. M., Nyce, J. W., Lewbart, M. L., and Pashko, L. L. Dehydroepiandrosterone and structural analogs: a new class of cancer chemopreventive agents. Adv. Cancer Res., 51: 391–424, 1988.
23. Slaga, T. J., and Scribner, J. D. Brief communication: inhibition of tumor initiation and promotion by anti-inflammatory agents. J. Natl. Cancer Inst., 57: 1723–1725, 1973.
24. Boutwell, R. K. Evidence that an elevated level of ornithine decarboxylase activity is an essential component of tumor promotion. Adv. Polyamine Res., 4: 127–131, 1982.
25. Weeks, C. E., Hermann, A. L., Nelson, F. R., and Slaga, T. J. Difluoro-methylornithine, an irreversible inhibitor of ornithine decarboxylase, inhibits tumor promoter-induced polyamine accumulation and carcinogensis in the mouse skin. Proc. Natl. Acad. Sci. USA, 79: 6028–6032, 1982.
26. Takigawa, M., Verma, A. K., Simsiman, R. C., and Boutwell, R. K. Inhibition of mouse skin tumor promotion and of promoter-stimulated epidermal polyamine biosynthesis by α-difluoromethylornithine. Cancer Res., 43: 3732–3738, 1983.
27. Kingsnorth, A. N., King, W. w. K., Diekema, K. A., McCann, P. P., Ross, J. S., and Malt, R. A. Inhibition of ornithine decarboxylase with 2-difIuoro-methyl-ornithine: reduced incidence of dimethylhydrazine-induced colon tumors in mice. Cancer Res., 43: 2545–2549, 1983.
28. Homma, Y., Ozono, Seiichiro, Numata, I., Seidenfeld, J., and Oyasu, R. Inhibition of carcinogensis by α-difluoromethylornithine in heterotopically transplanted rat urinary bladder. Cancer Res., 45: 648–652, 1985.
29. Thompson, H. J., Herbst, E. J., Meeker, L. D., Minocha, R., Ronan, A. M., and Fite, R. Effect of DL-a-difluoromethylomithine on murine mammary carcinogenesis. Carcinogenesis (Lond.), 5: 1649–1651, 1984.
30. Pollard, M., Luckert, P. H., Schmidt, M. A. The suppressive effect of piroxicam on autochthonous intestinal tumors in the rat. Cancer Lett., 21: 57–61, 1983.
31. Sharon, P., Ligumsky, M., Rachmilewitz, D., and Zov, U. Role of prostaglandins in ulcerative colitis. Gastroenterology, 75: 638–640, 1978.
32. Gould, S. R., Brash, A. R., Connolly, M. E., Leonard-Jones, J. E. Studies of prostaglandins and sulfasalazine in ulcerative colitis. Prostaglandins Med., 6: 165–182, 1981.
33. Narisawa, T., Sato, M., Tani, M., Kudo, T., Takahashi, T., and Goto, A. Inhibition of development of methylnitrosourea-induced rat colon tumors by indomethacin treatment. Cancer Res., 41: 1954–1957, 1981.
34. Lawson, T., and Stohs, S. Changes in endogenous DNA damage in aging mice in response to butylated hydroxyanisole and oltipraz. Mech. Ageing Dev., 30(2): 179–185, 1985.
35. Wattenberg, L. W. Inhibition of neoplasia by minor dietary constituents. Cancer Res., 43 (Suppl.): 2448s, 1983.
36. Mukhtar, H., Das, M., Del Tito, B. J., and Bickers, D. R. Protection against 3-methylcholanthrene-induced skin tumorigenesis in Balb/c mice by ellagic acid. Biochem. Biophys. Res. Commun., 119: 751–757, 1984.
37. Wattenberg, L. W. Inhibition of carcinogenic effects of polycyclic hydrocarbons by benzyl isothiocyanate and related compounds. J. Natl. Cancer Inst., 58: 395–398, 1977.
38. Wattenberg, L. W. Inhibition of carcinogen-induced neoplasia by sodium cyanate, /erf-butyl isocyanate, and benzyl isothiocyanate administered subsequent to carcinogen exposure. Cancer Res., 41: 2991–2994, 1981.
39. Wattenberg, L. W., and Loub, W. D. Inhibition of polycyclic aromatic hydrocarbon-induced neoplasia by naturally occurring indoles. Cancer Res., 38: 1410–1413, 1978.
40. Byers, T., Vena, J., Mettlin, C., Swanson, M., and Graham, S. Dietary vitamin A and lung cancer risk: an analysis by histologic subtypes. Am. J. Epidemiol., 120: 769–776, 1985.
41. Winn, D. M., Ziegler, K. G., Pickle, L. W. Diet in the etiology of oral and pharyngeal cancer among women from the southern United States. Cancer Res., 44:1216–1222, 1984.
42. Graham, S., Mettlin, C., Marshall, J., Priore, R., Rzepka, T., and Shedd, D. Dietary factors in the epidemiology of cancer of the larynx. Am. J. Epidemiol., 7/5: 675–680, 1981.
43. Mettlin, C., Graham, S., Prior, R., Marshall, J., and Swanson, M. Diet and cancer of the esophagus. Nutr. Cancer, 2: 143–147, 1981.
44. Haenszel, W., Kurihara, M., Segi, M., and Lee, R. K. C. Stomach cancer among Japanese in Hawaii. J. Natl. Cancer Inst., 9: 969–988, 1972.
45. Bjelke, E. Dietary factors and the epidemiology of cancer of the stomach and large bowel. Aktuel. Ernahrungsmed. Klin. Prax., 2 (Suppl.): 10–16, 1978.
46. Schuman, L. M., Mandell, J. S., Radke, A., Seal, U., and Halberg, F. Some selected features of the epidemilogy of prostate cancer: Minneapolis-St. Paul, Minnesota, case-control study, 1976–1979. In: K. Magnus (ed.), Trends in Cancer Incidence: Causes and Practical Implications, pp. 345–353. Washington, DC: Hemisphere Publishing Corp., 1982.
47. Shekelle, R. B., Liu, S., Raynor, W. J., Jr., Lepper, M., Maliza, C., and Rossaf, A. H. Dietary vitamin A and risk of cancer in the Western Electric Study. Lancet, 2: 1185–1190, 1981.
48. Stahelin, H. B., Rosel, F., Buesse, E., Brubacher, G. Cancer, vitamins, and plasma lipids: Prospective Basel study. J. Natl. Cancer Inst., 73: 1463–1468, 1984.
49. Nomura, A. M., Stemmermann, G. N., and Heilbrun, L. K. et al. Serum vitamin levels and the risk of cancer of specific sites in men of Japanese ancestry in Hawaii. Cancer Res., 45: 2369–2372, 1985.
50. Graham, S., Haughey, B., Marshall, J., Priore, R., Byers, T., Rzepka, T., Mettlin, C., and Pontes, J. E. Diet in the epidemiology of carcinoma of the prostate gland. J. Natl. Cancer Inst., 70: 687–692, 1983.
51. Heshmat, M. Y., Kaul, L., Kovi, J., Jackson, M. A., Jackson, A. G., Jones, G. W., Edson, M., Enterline, J. P., Worrell, R. G., and Perry, S. L. Nutrition and prostate cancer: a case-control study. The Prostate, 6: 7–17, 1985.
52. Moon, R. C., McCormick, D. L., and Mehta, R. G. Inhibition of carcinogensis by retinoids. Cancer Res., 43: 2469s, 1983.
53. Weisberger, J. H., Marquardt, H., Mower, H. F., Hirota, N., Mori, H., and Williams, G. Inhibition of carcinogenesis: vitamin C and the prevention of gastric cancer. Prev. Med., 9: 352–361, 1980.
54. Pipkin, G. E. et ai Inhibitory effect of L-ascorbate on tumor formation in urinary bladders implanted with 3-hydroxy-anthranilic acid. Proc. Soc. Exp. Biol. Med., 131: 522–524, 1969.
55. Aoki, K., Okada, H., Takeda, S., Segi, M., Ohno, Y., Sasaki, R., and Tominaga, S. Case control study on esophageal cancer in Japan. Proceedings of the 13th International Cancer Congress (Abstract 986), p. 175, 1982.
56. Kolonel, L. W., Nomura, A. M. Y., Hirohata, T., Hankin, J. H., and Hinds, M. W. Association of diet and place of birth with stomach cancer in Hawaiians, Japanese, and Caucasians. Am. J. Clin. Nutr., 34: 2478–2485, 1981.
57. Wassertheir-Smoller, S., Romney, S. L., Wylie-Rosett, J., Slagle, S., Miller, G., Lucido, D., Duttagupta, C., and Palan, P. R. Dietary vitamin C and uterine cervical dysplasia. Am. J. Epidemiol., 114: 714–724, 1981.
58. DeCosse, J. J., Adams, M. B., Kuzma, J. F., and Codon, R. E. Effect of ascorbic acid on rectal polyps of patients with familial polyposis. Surgery, 78: 608–612, 1975.
59. Bussey, J. H., DeCosse, J. J., and Deschner, E. E. A randomized trial of ascorbic acid in polyposis coli. Cancer (Phila.), 50: 1434–1439, 1982.
60. McKeown-Eyssen, G., Holloway, C., Jasmaji, V., Bright-see, E., Dion, P., and Bruce, W. R. A randomized trial of vitamins C and E in the prevention of recurrence of colorectal polyps. Cancer Res., 48: 4701–4705, 1988.
61. Block, G., and Menkes, M. Ascorbic acid in cancer prevention. T. Moon and M. Micozzi (eds.), In: Nutrition and Cancer Prevention: the Role of Micro-nutrients. New York: Marcel Dekker, 1988.
62. Newberne, P. M., and Suphakarn, V. Nutrition and cancer: a review, with emphasis on the role of vitamins C and E and selenium. Nutr. Cancer, 5: 107–119, 1983.
63. Willet, W. C., Polk, B. F., Underwood, B. A., Stampfer, M. J., Pressel, S., Rosner, B., Taylor, J. O., Schneider, K., and Hames, C. G. Relation of serum vitamins A and E and carotenoids to the risk of cancer. New Eng. J. Med., 5/0: 430–434, 1984.
64. Nomura, A. M. Y., Stemmermann, G. N., Heilbrun, L. K., Salkeld, R. M., and Vuillemumier, J. P. Serum vitamin levels and the risk of cancer of specific sites in Hawaiian males of Japanese ancestry. Cancer Res., 45: 2369–2372, 1985.
65. Wald, N. J., Boreham, J., Hayward, J. L., and Bulbrook, R. D. Plasma retinol, β-carotene, and vitamin E levels in relation to the future risk of breast cancer. Br. J. Cancer, 49: 321–324, 1984.
66. Menkes, M., and Comstock, G. Vitamins A and E and lung cancer. Am. J. Epidemiol., 120: 342–349, 1984.
67. Gey, K. F., Brubacher, G. B., and Stahelin, H. B. Plasma levels of antioxidant vitamins in relation to ischemic heart disease and cancer. Am. J. Clin. Nutr., 45: 1368–1377, 1987.
68. Heinonen, P. K., Koskinen, T., and Tuimala, R. Serum levels of vitamins A and E in women with ovarian cancer. Arch. Gynecol., 237: 37–40, 1985.
69. Wargovich, M. J., Eng, V. W. S., Newmark, H. L., and Bruce, W. R. Calcium ameliorates the toxic effect of deoxycholic acid on colonic epithelium. Carcinogenesis (Lond.), 4: 1205–1207, 1983.
70. Bird, R. P., Schneider, R. Stamp, D., and Bruce, W. R. Effect of dietary calcium and cholic acid on the proliferative indices of murine colonic epithelium. Carcinogenesis (Lond.), 7: 1657–1661, 1986.
71. Wargovich, M. J., Eng, V. W. S., Newmark, H. L., and Bruce, W. R. Calcium inhibits the damaging and compensating proliferative effects of fatty acids on mouse colon epithelium. Cancer Lett., 23: 253–258, 1984.
72. Appleton, G. V. N., Davies, P. W., Bristol, J. B., and Williamson, R. C. N. Inhibition of intestinal carcinogenesis by dietary supplementation with calcium. Br. J. Surg., 74: 523–525, 1987.
73. Pence, B. C., and Buddingh, F. Inhibition of dietary fat promotion of colon carcinogenesis by supplemental calcium or vitamin D. Proc. Am. Assoc. Cancer Res., 28: 154, 1957.
74. Butterworth, C. E., Hatch, K. D., Gore, H., Mueller, H., and Krumdieck, C. L. Improvement in cervical dysplasia associated with folic acid therapy in users of oral contraceptives. Am. J. Clin. Nutr., 35: 73–82, 1982.
75. Shaklar, G. et al. The effect of methotrexate on chemical carcinogenesis in the hamster buccal pouch. Cancer Res., 26: 2218–2224, 1966.
76. DeWys, W. D., Malone, W. F., Butrum, R., and Sestili, M. A. Clinical trials in cancer prevention. Cancer (Phila.), 58: 1954–1962, 1986.
77. Malone, W. F., Kelloff, G. J., Pierson, H., and Greenwald, P. Chemoprevention of bladder cancer. Cancer (Phila.), 60: 650–657, 1987.
78. Rous, P., and Kidd, J. G. Conditional neoplasms and subthreshold neoplastic states. A study of tar tumors in rabbits. J. Exp., 73: 365–389, 1941.
79. Berenblum, I., and Shubik, P. A. New, quantitative approach to the study of the stages of chemical carcinogenesis in the mouse skin. Br. J. Cancer, 1: 383–391, 1947.
80. Slaga, T. J., Fischer, S. M., Weeks, C. E., Nelson, K., Mamrake, M., and Klein-Szants, A. J. Specificity and Mechanisms of Promoter Inhibitors in Multistage Promotion. Carcinog. Compr. Surv., 7: 19–34, 1982.
81. Yuspa, S. H. Mechanisms of transformation and promotion of mouse epidermal cells. Carginog. Compr. Surv., 9: 271–282, 1985.
82. Foulds, L. Neoplastic Development. New York: Academic Press, 1975.
83. Nowell, P. C. The clonal evolution of tumor cell populations. Science (Wash. DC), 794: 23–28, 1976.
84. Sudilovsky, O., and Liotta, L. A. Boundaries between Promotion and Progression during Carcinogenesis. New York: Plenum Publishing Corp., in press, 1990.
85. Diet, Nutrition, and Cancer. Committee on Diet, Nutrition and Cancer, Assembly of Life Sciences, National Research Council, National Academy Press, Washington, DC, 1982.